These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25171061)
21. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma. Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma. Zhang G; Liu T; Wang Z J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217 [TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma. Jiang LH; Hao YL; Zhu JW Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):282-291. PubMed ID: 30385249 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
25. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012 [TBL] [Abstract][Full Text] [Related]
26. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma. Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma. Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205 [TBL] [Abstract][Full Text] [Related]
28. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma. Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329 [TBL] [Abstract][Full Text] [Related]
29. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801 [TBL] [Abstract][Full Text] [Related]
30. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438 [TBL] [Abstract][Full Text] [Related]
31. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Gu H; Guo X; Zou L; Zhu H; Zhang J Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979 [TBL] [Abstract][Full Text] [Related]
33. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Xia D; Yan LN; Xie JG; Tong Y; Yan ML; Wang XP; Zhang MM; Zhao LY Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):409-15. PubMed ID: 16911941 [TBL] [Abstract][Full Text] [Related]
35. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma. Matsumoto E; Nakatsukasa H; Nouso K; Kobayashi Y; Nakamura S; Suzuki M; Takuma Y; Tanaka H; Fujikawa T; Shiratori Y Liver Int; 2004 Aug; 24(4):379-83. PubMed ID: 15287862 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391 [TBL] [Abstract][Full Text] [Related]
37. Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma: Strobe-Compliant Article. Chen R; Zhou X; Yu Z; Liu J; Huang G Medicine (Baltimore); 2015 Sep; 94(39):e1583. PubMed ID: 26426634 [TBL] [Abstract][Full Text] [Related]
38. Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma. Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Ren Y; Chen H; Sun SN; Huang M; Li JS PLoS One; 2014; 9(1):e85840. PubMed ID: 24465741 [TBL] [Abstract][Full Text] [Related]
39. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma. Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581 [TBL] [Abstract][Full Text] [Related]
40. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]